 growth factors chronic liver disease Effects interferon alfa therapy BACKGROUND Cirrhosis diffuse process hepatic fibrosis regenerative nodule formation unknown pathogenesis growth factor TGF induces production extracellular matrix proteins liver cells pathogenesis hepatic fibrosis laboratory animals TGF alpha hepatocyte mitogen liver regeneration METHODS Northern blot analysis expression TGF beta messenger RNA mRNA liver specimens patients chronic hepatitis cirrhosis subjects normal fatty livers results measurements procollagen Type liver tissue procollagen Type III peptide serum degree histologic injury TGF alpha mRNA detectable biopsy specimens livers proliferative activity RESULTS TGF mRNA expression expression procollagen Type serum procollagen Type III peptide histologic activity index patients increased fibrogenic activity serum procollagen Type III level micrograms liter levels TGF beta mRNA times levels control group patients normal fibrogenic activity TGF alpha histone marker DNA synthesis mRNAs detectable patients regenerative nodules patients hepatitis interferon alfa year clinical responses normalization serum procollagen Type III peptide aminotransferase activity patients normal levels TGF beta mRNA liver specimens end year CONCLUSIONS TGF important role pathogenesis fibrosis patients chronic liver disease TGF expression liver regeneration patients